These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7716453)

  • 1. [Should a preventive congenital toxoplasmosis program be established in Switzerland?].
    Raeber PA
    Schweiz Med Wochenschr Suppl; 1995; 65():5S-9S. PubMed ID: 7716453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention of congenital toxoplasmosis in Europe].
    Raeber PA; Biedermann K; Just M; Zuber P
    Schweiz Med Wochenschr Suppl; 1995; 65():96S-102S. PubMed ID: 7716459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation of preventive programmes against congenital toxoplasmosis.
    Stray-Pedersen B; Jenum P
    Scand J Infect Dis Suppl; 1992; 84():86-96. PubMed ID: 1290083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Toxoplasmosis in pregnancy: prevention, prenatal diagnosis and treatment].
    Hohlfeld P; Biedermann K; Extermann P; Gyr T
    Schweiz Med Wochenschr Suppl; 1995; 65():62S-69S. PubMed ID: 7716455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of prevention strategies for congenital toxoplasmosis: a critical review of medico-economic studies].
    Binquet C; Wallon M; Quantin C; Gadreau M; Peyron F
    Rev Epidemiol Sante Publique; 2002 Oct; 50(5):475-87. PubMed ID: 12471340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of congenital toxoplasmosis in Switzerland. Consensus report of the study group "Congenital toxoplasmosis" of the federal public health office].
    Raeber PA; Berger R; Biedermann K; Billo N; Extermann P; Hartmann D; Heimann P; Herzog C; Hohlfeld P; Jacquier P
    Schweiz Med Wochenschr Suppl; 1995; 65():113S-120S. PubMed ID: 7716448
    [No Abstract]   [Full Text] [Related]  

  • 7. [-Toxoplasmosis in pregnancy: arguments in favor of systematic screening in Switzerland-].
    Hohlfeld P
    Arch Gynecol Obstet; 1995; 256 Suppl():S165-9. PubMed ID: 8619652
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cost-benefit analysis of screening for congenital toxoplasmosis].
    Sagmeister M; Gessner U; Kind C; Horisberger B
    Schweiz Med Wochenschr Suppl; 1995; 65():103S-112S. PubMed ID: 7716447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening programme for congenital toxoplasmosis in France.
    Thulliez P
    Scand J Infect Dis Suppl; 1992; 84():43-5. PubMed ID: 1290073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the possibilities for preventing congenital toxoplasmosis.
    Foulon W; Naessens A; Derde MP
    Am J Perinatol; 1994 Jan; 11(1):57-62. PubMed ID: 8155214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of congenital toxoplasmosis in France. Risk assessment. Results and perspectives of prenatal screening and newborn follow up].
    Ambroise-Thomas P; Schweitzer M; Pinon JM; Thiebaugeorges O
    Bull Acad Natl Med; 2001; 185(4):665-83; discussion 684-8. PubMed ID: 11503357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [-Screening for toxoplasmosis in pregnancy-].
    Extermann P
    Arch Gynecol Obstet; 1995; 256 Suppl():S170-2. PubMed ID: 8619653
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prenatal diagnosis and treatment of congenital toxoplasmosis: a program of regional surveillance].
    Todros T; Oliveri MG; Verdiglione P; Zotti C; Moiraghi Ruggenini A; Charrier L; Mombrò M; Perathoner C; Leone A; Fabris C
    Minerva Ginecol; 2000 Dec; 52(12 Suppl 1):123-34. PubMed ID: 11526681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiology of toxoplasmosis in Switzerland: national study of seroprevalence monitored in pregnant women 1990-1991].
    Jacquier P; Hohlfeld P; Vorkauf H; Zuber P
    Schweiz Med Wochenschr Suppl; 1995; 65():29S-38S. PubMed ID: 7716451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital toxoplasmosis--prenatal aspects of Toxoplasma gondii infection.
    Rorman E; Zamir CS; Rilkis I; Ben-David H
    Reprod Toxicol; 2006 May; 21(4):458-72. PubMed ID: 16311017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital toxoplasmosis: priorities for further health promotion action.
    Elsheikha HM
    Public Health; 2008 Apr; 122(4):335-53. PubMed ID: 17964621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of toxoplasmosis during pregnancy--an epidemiologic survey over 22 consecutive years.
    Breugelmans M; Naessens A; Foulon W
    J Perinat Med; 2004; 32(3):211-4. PubMed ID: 15188792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prenatal toxoplasmosis--do we need screening in pregnancy?].
    Friese K; Hlobil H
    Z Geburtshilfe Neonatol; 1997; 201(4):115-20. PubMed ID: 9410515
    [No Abstract]   [Full Text] [Related]  

  • 19. Congenital toxoplasmosis: late pregnancy infections detected by neonatal screening and maternal serological testing at delivery.
    Lago EG; Neto EC; Melamed J; Rucks AP; Presotto C; Coelho JC; Parise C; Vargas PR; Goldbeck AS; Fiori RM
    Paediatr Perinat Epidemiol; 2007 Nov; 21(6):525-31. PubMed ID: 17937738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cord blood screening for congenital toxoplasmosis in northwestern Switzerland, 1982-1999.
    Signorell LM; Seitz D; Merkel S; Berger R; Rudin C
    Pediatr Infect Dis J; 2006 Feb; 25(2):123-8. PubMed ID: 16462288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.